These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7995942)

  • 21. Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes.
    Coles RM; Jones CM; Brooks AG; Cameron PU; Heath WR; Carbone FR
    Eur J Immunol; 2003 Jun; 33(6):1557-67. PubMed ID: 12778473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
    Shier P; Ngo K; Fung-Leung WP
    J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity.
    Hornell TM; Myers N; Hansen TH; Connolly JM
    J Immunol; 2003 May; 170(9):4506-14. PubMed ID: 12707327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells.
    Epel M; Ellenhorn JD; Diamond DJ; Reiter Y
    Cancer Immunol Immunother; 2002 Nov; 51(10):565-73. PubMed ID: 12384808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self peptide/MHC class I complexes have a negligible effect on the response of some CD8+ T cells to foreign antigen.
    Spörri R; Reis e Sousa C
    Eur J Immunol; 2002 Nov; 32(11):3161-70. PubMed ID: 12555661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class I-restricted cytotoxic T cell recognition of split peptide ligands.
    Gillanders WE; Hanson HL; Rubocki RJ; Hansen TH; Connolly JM
    Int Immunol; 1997 Jan; 9(1):81-9. PubMed ID: 9043950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional evidence that conserved TCR CDR alpha 3 loop docking governs the cross-recognition of closely related peptide:class I complexes.
    Messaoudi I; LeMaoult J; Metzner BM; Miley MJ; Fremont DH; Nikolich-Zugich J
    J Immunol; 2001 Jul; 167(2):836-43. PubMed ID: 11441090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway.
    Rötzschke O; Falk K
    Immunol Today; 1991 Dec; 12(12):447-55. PubMed ID: 1723878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. For T cell receptors, some breakups might not last forever.
    Govern CC; Chakraborty AK
    Immunity; 2010 Feb; 32(2):141-2. PubMed ID: 20189475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunology. The ins and outs of antigen processing and presentation.
    Germain RN
    Nature; 1986 Aug 21-27; 322(6081):687-9. PubMed ID: 3489186
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional segregation of the TCR and antigen-MHC complexes on the surface of CTL.
    Mekala DJ; Geiger TL
    J Immunol; 2003 Oct; 171(8):4089-95. PubMed ID: 14530330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central tolerance to self-antigen expressed by cortical epithelial cells.
    Mayerova D; Hogquist KA
    J Immunol; 2004 Jan; 172(2):851-6. PubMed ID: 14707055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-specific blockade of T cells in vivo using dimeric MHC peptide.
    O'Herrin SM; Slansky JE; Tang Q; Markiewicz MA; Gajewski TF; Pardoll DM; Schneck JP; Bluestone JA
    J Immunol; 2001 Sep; 167(5):2555-60. PubMed ID: 11509595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant.
    Wallny HJ; Deres K; Faath S; Jung G; Van Pel A; Boon T; Rammensee HG
    Int Immunol; 1992 Oct; 4(10):1085-90. PubMed ID: 1283332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour-reactive cytotoxic T-lymphocytes specific for normal cellular proteins.
    Stauss HJ; Dahl M; Sadovnikova E
    Biochem Soc Trans; 1997 May; 25(2):540-3. PubMed ID: 9191152
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemistry of peptide interactions with MHC proteins.
    Sette A; Grey HM
    Curr Opin Immunol; 1992 Feb; 4(1):79-86. PubMed ID: 1596372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy.
    Sadegh-Nasseri S; Dalai SK; Korb Ferris LC; Mirshahidi S
    Immunology; 2010 Jan; 129(1):1-7. PubMed ID: 20002785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the complexity and malleability of T-cell recognition.
    Miles JJ; McCluskey J; Rossjohn J; Gras S
    Immunol Cell Biol; 2015; 93(5):433-41. PubMed ID: 25582337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cells function via restricted recognition of antigen, not antigen-restricted recognition.
    Langman RE; Cohn M
    Cell Immunol; 1985 Sep; 94(2):598-608. PubMed ID: 2411430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.